Todd joins Swan after more than 25 years of leadership at Stryker. Most recently, he served as VP and GM of the orthopedic giant’s Robotics and Enabling Technologies unit. Todd announced his departure from Stryker last month.
He now leads Swan, which was born out of a joint venture involving a medtech giant earlier this year. In July, Olympus agreed to jointly invest $458 million with private equity investment firm Revival Healthcare Capital, establishing Swan EndoSurgical. It has a goal of creating new, significantly enhanced minimally invasive treatment options for unmet needs. The company is focused on developing a fully integrated, flexible endoluminal robotic platform for complex gastrointestinal interventions.
(Olympus CEO Bob White spoke to MassDevice recently about the venture and its aims. Read about it here.)
Swan EndoSurgical said Todd brings deep experience scaling next-generation robotic platforms, helping to oversee the advancement of its Mako platform. Stryker also struck a deal with Siemens Healthineers earlier this year to develop a unique robotic system capable of performing a range of neurovascular procedures.
The company said Todd’s track record includes building high-performance global engineering organizations. He also has experience driving innovation across endoscopy, minimally invasive surgery, and digital/AI-enabled enabling technologies.
Visit here to purchase MassDevice’s latest Medtech Market Special Report on Surgical Robotics.
Commentary from Swan EndoSurgical leadership
Bob White, Olympus CEO and Swan’s representative executive officer, said:
“The appointment of Erik to Swan EndoSurgical as the CEO marks a pivotal step in advancing our shared vision for endoluminal robotics. Together, we are committed to transforming gastrointestinal care through breakthrough robotics, empowering physicians, and delivering safer, less invasive solutions for patients everywhere.”
Justin Ballotta, managing director at Revival Healthcare Capital and head of post-investment value creation, said:
“Erik is an accomplished and respected leader in surgical robotics. With a proven track record of scaling sophisticated robotics platforms from concept through commercialization, Erik brings a global perspective, strategic rigor, and a deep appreciation for clinical needs making him the ideal leader for Swan.”
New Swan CEO Erik Todd added:
“I am excited to join Swan EndoSurgical and help advance endoluminal surgery. Building on the foundation created by Swan, Revival, and Olympus, we can address unmet needs in advanced GI interventions using robotics, visualization, and flexible access. I look forward to collaborating with Olympus, health care professionals, and our teams to develop, deliver, and scale meaningful innovations for patients around the world.”
Medical Design & Outsourcing: Download our free 72-page Min-Vasive Medtech Special Report featuring interviews with minimally invasive device development experts and engineers at major OEMs and groundbreaking startups
